March 8, 2018 / 12:23 PM / 3 months ago

BRIEF-Melinta Therapeutics Partner, Menarini Group, Submits Marketing Authorization Application For Delafloxacin In Europe

March 8 (Reuters) - Melinta Therapeutics, Inc.:

* MELINTA THERAPEUTICS PARTNER, MENARINI GROUP, SUBMITS MARKETING AUTHORIZATION APPLICATION FOR DELAFLOXACIN IN EUROPE

* MELINTA THERAPEUTICS, INC. - MENARINI GROUP SUBMITTED MARKETING AUTHORIZATION APPLICATION TO EUROPEAN MEDICINES AGENCY FOR DELAFLOXACIN Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below